Sign in
Stories
Breakthrough Therapy Shows Positive Results
Share
Advancements in Cancer Treatment and Mar...
Advancements in Clinical Trials
AnaMar Receives Orphan Drug Designation ...
AI-Powered Cancer Drug Trials
Advancing CD70 Targeted Cancer Treatment...
Affini-T Therapeutics at J.P. Morgan Hea...
Overview
API
Mustang Bio's MB-101 shows promising results in treating malignant glioma, with significant complete responses and improved survival rates. Dr. Christine Brown and CEO Manuel Litchman express optimism for transformative treatment approaches.
Ask a question
How could the success of MB-101 impact the future of cancer treatment research?
How does MB-101's performance compare to existing treatments for malignant glioma?
What challenges might arise in the upcoming trials of MB-101?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage